We are live on
!
Find out more
CGA
Compound Global Advisors Portfolio holdings
AUM
$3.22M
1-Year Est. Return
30.08%
This Fund
S&P 500
This Quarter
Est. Return
-1.33%
1 Year Est. Return
+30.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$456M
AUM Growth
+$22.8M
(+5.2%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
8.26%
Top 10 Holdings %
Top 10 Hldgs %
46.86%
Holding
43
New
10
Increased
12
Reduced
10
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$15M |
| 2 |
InMode
INMD
|
+$11.5M |
| 3 |
Ulta Beauty
ULTA
|
+$11.1M |
| 4 |
AutoZone
AZO
|
+$10.2M |
| 5 |
WillScot Mobile Mini Holdings
WSC
|
+$8.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$16.2M |
| 2 |
Wyndham Hotels & Resorts
WH
|
+$11.3M |
| 3 |
Diageo
DEO
|
+$9.98M |
| 4 |
Intercontinental Exchange
ICE
|
+$9.22M |
| 5 |
UnitedHealth
UNH
|
+$8.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.98% |
| 2 | Financials | 14.34% |
| 3 | Technology | 14.04% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Energy | 11.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$261B
| $7.66M | 1.68% |
+56,529
| New | +$7.72M |
|
27
EQT Corp
EQT
$33.4B
| $7.22M | 1.58% |
177,894
-193,935
| -52% | -$8.03M |
|
28
Thermo Fisher Scientific
TMO
$213B
| $7.08M | 1.55% |
13,990
-7,936
| -36% | -$4.23M |
|
29
ASML
ASML
$693B
| $6.3M | 1.38% |
10,707
+2,785
| +35% | +$1.85M |
|
30
Boston Scientific
BSX
$64.8B
| $5.06M | 1.11% |
+95,755
| New | +$5.02M |
|
31
S&P Global
SPGI
$124B
| $4.84M | 1.06% |
+13,255
| New | +$5.21M |
|
32
Prologis
PLD
$135B
| $4.64M | 1.02% |
+41,314
| New | +$5.05M |
|
33
Wheaton Precious Metals
WPM
$50B
| $4.5M | 0.99% |
111,070
| – | – |
|
|
NVO
34
Novo Nordisk
NVO
$213B
| $3.88M | 0.85% |
+42,688
| New | +$3.76M |
|
35
Eli Lilly
LLY
$1.06T
| $1.41M | 0.31% |
+8,238
| New | +$4.24M |
|
36
ConocoPhillips
COP
$146B
| – | – |
-68,499
| Closed | -$7.1M |
|
|
37
Diageo
DEO
$45.7B
| – | – |
-57,555
| Closed | -$9.98M |
|
38
Danaher
DHR
$135B
| – | – |
-33,427
| Closed | -$7.11M |
|
|
39
Intercontinental Exchange
ICE
$81B
| – | – |
-81,492
| Closed | -$9.22M |
|
40
JPMorgan Chase
JPM
$930B
| – | – |
-30,991
| Closed | -$4.51M |
|
41
Procter & Gamble
PG
$342B
| – | – |
-47,041
| Closed | -$7.14M |
|
|
42
Royalty Pharma
RPRX
$26.2B
| – | – |
-543,920
| Closed | -$16.2M |
|
|
43
Wyndham Hotels & Resorts
WH
$5.5B
| – | – |
-164,073
| Closed | -$11.3M |
|
Similar funds
RCP
EAMS
HFA
KI
1IC
WH
SRB
BPM
Compound Global Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Compound Global Advisors held 43 positions worth $456M, up 5.2% from $433M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Compound Global Advisors deployed $37.7M of net new capital in Q3 2023, opening 10 new positions and adding to 12 existing holdings. Its largest new stake was Alphabet (Google) Class A: 116,052 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was UnitedHealth, an estimated $8.69M trimmed.
- Compound Global Advisors's largest Q3 2023 buy was Alphabet (Google) Class A: 116,052 shares worth $15.2M.
- Compound Global Advisors added most to InMode in Q3 2023, an estimated $11.5M increase.
- Compound Global Advisors's biggest Q3 2023 reduction was UnitedHealth, cutting an estimated $8.69M.
- Compound Global Advisors fully exited Royalty Pharma in Q3 2023, selling an estimated $16.2M.
- Compound Global Advisors's ten largest holdings make up 47% of its $456M portfolio in Q3 2023.
- Compound Global Advisors opened 10 new positions and closed 8 in Q3 2023.
- Compound Global Advisors's portfolio value rose 5.2% quarter-over-quarter to $456M.
Based on Compound Global Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.